Skip to main content
Clinical Trials/EUCTR2007-002078-71-NL
EUCTR2007-002078-71-NL
Active, not recruiting
Not Applicable

Reductie van Hersenschade na Perinatal Arterial Stroke”of PAS met recombinant humaan Erythropoietine (rhEPO): Een Proof of Concept” en Safety” studie - reduction of braindamage after rhEPO

Wilhelmina Children's Hospital/UMC Utrecht0 sites30 target enrollmentNovember 23, 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Wilhelmina Children's Hospital/UMC Utrecht
Enrollment
30
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 23, 2007
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Wilhelmina Children's Hospital/UMC Utrecht

Eligibility Criteria

Inclusion Criteria

  • Newborn infants with gestational age more than 36 weeks admitted to the NICU, with diagnosis perinatal arterial stroke (often Middle Cerebral artery) diagnosed with cerebral ultrasound and/or cerebral MRI/MRA .
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Congenital and/or chromosomal problems.

Outcomes

Primary Outcomes

Not specified

Similar Trials